[Holding option open for subsequent treatment. Beginning therapy with a protease inhibitor].
D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D019888:Nelfinavir / Q000008:administration & dosage / Q000009:adverse effects; D019562:Viral Load
D017320:HIV Protease Inhibitors; D019888:Nelfinavir